A possible explanation for the increase in FGF-21 concentration in our subjects with NAFLD may be due to a feedback-induced protective response against hepatic steatosis or an FGF-21-resistant state (15, 26). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.